{"columns": ["compound_id", "compound_name", "disease_id", "disease_name", "category", "prediction", "compound_percentile", "disease_percentile", "n_trials"], "data": [["DB00188", "Bortezomib", "DOID:10652", "Alzheimer's disease", null, 0.004455, 0.875, 0.882965, 0], ["DB00188", "Bortezomib", "DOID:9206", "Barrett's esophagus", null, 0.003566, 0.808824, 0.936281, 0], ["DB00188", "Bortezomib", "DOID:13241", "Behcet's disease", null, 0.001667, 0.382353, 0.745124, 0], ["DB00188", "Bortezomib", "DOID:11949", "Creutzfeldt-Jakob disease", null, 0.001532, 0.205882, 0.691808, 0], ["DB00188", "Bortezomib", "DOID:8778", "Crohn's disease", null, 0.002543, 0.610294, 0.830299, 0], ["DB00188", "Bortezomib", "DOID:11555", "Fuchs' endothelial dystrophy", null, 0.001405, 0.073529, 0.618336, 0], ["DB00188", "Bortezomib", "DOID:11119", "Gilles de la Tourette syndrome", null, 0.001553, 0.272059, 0.604681, 0], ["DB00188", "Bortezomib", "DOID:12361", "Graves' disease", null, 0.00262, 0.632353, 0.896619, 0], ["DB00188", "Bortezomib", "DOID:2986", "IgA glomerulonephritis", null, 0.001338, 0.022059, 0.710663, 0], ["DB00188", "Bortezomib", "DOID:13378", "Kawasaki disease", null, 0.002526, 0.602941, 0.901821, 0], ["DB00188", "Bortezomib", "DOID:5408", "Paget's disease of bone", null, 0.001949, 0.463235, 0.776333, 0], ["DB00188", "Bortezomib", "DOID:14330", "Parkinson's disease", null, 0.001888, 0.455882, 0.715865, 0], ["DB00188", "Bortezomib", "DOID:7693", "abdominal aortic aneurysm", null, 0.001547, 0.227941, 0.693108, 0], ["DB00188", "Bortezomib", "DOID:635", "acquired immunodeficiency syndrome", null, 0.00472, 0.897059, 0.855007, 0], ["DB00188", "Bortezomib", "DOID:3953", "adrenal gland cancer", null, 0.001552, 0.264706, 0.644343, 0], ["DB00188", "Bortezomib", "DOID:10871", "age related macular degeneration", null, 0.00143, 0.110294, 0.659948, 0], ["DB00188", "Bortezomib", "DOID:0050741", "alcohol dependence", null, 0.0029, 0.676471, 0.684005, 0], ["DB00188", "Bortezomib", "DOID:4481", "allergic rhinitis", null, 0.003488, 0.794118, 0.754876, 0], ["DB00188", "Bortezomib", "DOID:986", "alopecia areata", null, 0.001665, 0.375, 0.651495, 0], ["DB00188", "Bortezomib", "DOID:332", "amyotrophic lateral sclerosis", null, 0.002553, 0.617647, 0.918075, 0], ["DB00188", "Bortezomib", "DOID:2355", "anemia", null, 0.001846, 0.448529, 0.762679, 0], ["DB00188", "Bortezomib", "DOID:7147", "ankylosing spondylitis", null, 0.002266, 0.544118, 0.769831, 0], ["DB00188", "Bortezomib", "DOID:11239", "appendix cancer", null, 0.00155, 0.235294, 0.687906, 0], ["DB00188", "Bortezomib", "DOID:2841", "asthma", null, 0.004012, 0.860294, 0.737321, 0], ["DB00188", "Bortezomib", "DOID:1936", "atherosclerosis", null, 0.002979, 0.691176, 0.802991, 0], ["DB00188", "Bortezomib", "DOID:3310", "atopic dermatitis", null, 0.003011, 0.698529, 0.741873, 0], ["DB00188", "Bortezomib", "DOID:1094", "attention deficit hyperactivity disorder", null, 0.001443, 0.125, 0.514304, 0], ["DB00188", "Bortezomib", "DOID:12849", "autistic disorder", null, 0.001375, 0.058824, 0.498049, 0], ["DB00188", "Bortezomib", "DOID:14227", "azoospermia", null, 0.002662, 0.647059, 0.881664, 0], ["DB00188", "Bortezomib", "DOID:4606", "bile duct cancer", null, 0.001417, 0.088235, 0.659948, 0], ["DB00188", "Bortezomib", "DOID:3312", "bipolar disorder", null, 0.001486, 0.154412, 0.535111, 0], ["DB00188", "Bortezomib", "DOID:184", "bone cancer", null, 0.00464, 0.889706, 0.953836, 0], ["DB00188", "Bortezomib", "DOID:1319", "brain cancer", null, 0.00566, 0.948529, 0.977243, 0], ["DB00188", "Bortezomib", "DOID:1612", "breast cancer", null, 0.006331, 0.970588, 0.881014, 0], ["DB00188", "Bortezomib", "DOID:10608", "celiac disease", null, 0.00158, 0.301471, 0.731469, 0], ["DB00188", "Bortezomib", "DOID:4362", "cervical cancer", null, 0.001964, 0.470588, 0.781534, 0], ["DB00188", "Bortezomib", "DOID:784", "chronic kidney failure", null, 0.003035, 0.713235, 0.873862, 0], ["DB00188", "Bortezomib", "DOID:3083", "chronic obstructive pulmonary disease", null, 0.005651, 0.933824, 0.89857, 0], ["DB00188", "Bortezomib", "DOID:9296", "cleft lip", null, 0.001382, 0.066176, 0.652796, 0], ["DB00188", "Bortezomib", "DOID:219", "colon cancer", null, 0.002343, 0.551471, 0.784785, 0], ["DB00188", "Bortezomib", "DOID:12995", "conduct disorder", null, 0.001527, 0.198529, 0.578023, 0], ["DB00188", "Bortezomib", "DOID:3393", "coronary artery disease", null, 0.017594, 0.985294, 0.954486, 0], ["DB00188", "Bortezomib", "DOID:90", "degenerative disc disease", null, 0.001552, 0.257353, 0.689857, 0], ["DB00188", "Bortezomib", "DOID:216", "dental caries", null, 0.001306, 0.007353, 0.602731, 0], ["DB00188", "Bortezomib", "DOID:12930", "dilated cardiomyopathy", null, 0.003576, 0.816176, 0.921326, 0], ["DB00188", "Bortezomib", "DOID:10021", "duodenum cancer", null, 0.001606, 0.345588, 0.703511, 0], ["DB00188", "Bortezomib", "DOID:1595", "endogenous depression", null, 0.00223, 0.522059, 0.828999, 0], ["DB00188", "Bortezomib", "DOID:1826", "epilepsy syndrome", null, 0.038302, 0.992647, 0.947334, 0], ["DB00188", "Bortezomib", "DOID:5041", "esophageal cancer", null, 0.004998, 0.926471, 0.973342, 0], ["DB00188", "Bortezomib", "DOID:1964", "fallopian tube cancer", null, 0.001668, 0.389706, 0.737971, 0], ["DB00188", "Bortezomib", "DOID:1312", "focal segmental glomerulosclerosis", null, 0.002152, 0.492647, 0.791938, 0], ["DB00188", "Bortezomib", "DOID:3121", "gallbladder cancer", null, 0.001515, 0.191176, 0.718466, 0], ["DB00188", "Bortezomib", "DOID:2994", "germ cell cancer", null, 0.003592, 0.823529, 0.940182, 0], ["DB00188", "Bortezomib", "DOID:11714", "gestational diabetes", null, 0.002183, 0.5, 0.738622, 0], ["DB00188", "Bortezomib", "DOID:1686", "glaucoma", null, 0.002782, 0.654412, 0.746424, 0], ["DB00188", "Bortezomib", "DOID:13189", "gout", null, 0.002972, 0.683824, 0.70091, 0], ["DB00188", "Bortezomib", "DOID:11934", "head and neck cancer", null, 0.003325, 0.779412, 0.939532, 0], ["DB00188", "Bortezomib", "DOID:2531", "hematologic cancer", "DM", 0.004102, 0.867647, 0.760728, 0], ["DB00188", "Bortezomib", "DOID:2043", "hepatitis B", null, 0.001813, 0.441176, 0.622887, 0], ["DB00188", "Bortezomib", "DOID:10763", "hypertension", null, 0.013654, 0.977941, 0.859558, 0], ["DB00188", "Bortezomib", "DOID:1459", "hypothyroidism", null, 0.002261, 0.536765, 0.773082, 0], ["DB00188", "Bortezomib", "DOID:0050156", "idiopathic pulmonary fibrosis", null, 0.001552, 0.242647, 0.730169, 0], ["DB00188", "Bortezomib", "DOID:10153", "ileum cancer", null, 0.001581, 0.308824, 0.692458, 0], ["DB00188", "Bortezomib", "DOID:10941", "intracranial aneurysm", null, 0.001552, 0.25, 0.716515, 0], ["DB00188", "Bortezomib", "DOID:13499", "jejunal cancer", null, 0.001582, 0.316176, 0.693758, 0], ["DB00188", "Bortezomib", "DOID:263", "kidney cancer", null, 0.004915, 0.911765, 0.907022, 0], ["DB00188", "Bortezomib", "DOID:2596", "larynx cancer", null, 0.001608, 0.352941, 0.747724, 0], ["DB00188", "Bortezomib", "DOID:1024", "leprosy", null, 0.003368, 0.786765, 0.920676, 0], ["DB00188", "Bortezomib", "DOID:3571", "liver cancer", null, 0.003107, 0.720588, 0.916775, 0], ["DB00188", "Bortezomib", "DOID:1324", "lung cancer", null, 0.004581, 0.882353, 0.877113, 0], ["DB00188", "Bortezomib", "DOID:0060073", "lymphatic system cancer", null, 0.002186, 0.507353, 0.797139, 0], ["DB00188", "Bortezomib", "DOID:12365", "malaria", null, 0.003951, 0.852941, 0.864759, 0], ["DB00188", "Bortezomib", "DOID:3070", "malignant glioma", null, 0.003018, 0.705882, 0.927828, 0], ["DB00188", "Bortezomib", "DOID:1790", "malignant mesothelioma", null, 0.001502, 0.169118, 0.655397, 0], ["DB00188", "Bortezomib", "DOID:5559", "mediastinal cancer", null, 0.001617, 0.360294, 0.717165, 0], ["DB00188", "Bortezomib", "DOID:1909", "melanoma", null, 0.00244, 0.588235, 0.8329, 0], ["DB00188", "Bortezomib", "DOID:10976", "membranous glomerulonephritis", null, 0.001562, 0.286765, 0.708062, 0], ["DB00188", "Bortezomib", "DOID:3565", "meningioma", null, 0.001352, 0.036765, 0.643043, 0], ["DB00188", "Bortezomib", "DOID:14221", "metabolic syndrome X", null, 0.001689, 0.397059, 0.643043, 0], ["DB00188", "Bortezomib", "DOID:5099", "middle ear cancer", null, 0.001421, 0.102941, 0.588427, 0], ["DB00188", "Bortezomib", "DOID:6364", "migraine", null, 0.003126, 0.727941, 0.661899, 0], ["DB00188", "Bortezomib", "DOID:2377", "multiple sclerosis", null, 0.002428, 0.580882, 0.702861, 0], ["DB00188", "Bortezomib", "DOID:4045", "muscle cancer", null, 0.005828, 0.955882, 0.963589, 0], ["DB00188", "Bortezomib", "DOID:8986", "narcolepsy", null, 0.001357, 0.044118, 0.503251, 0], ["DB00188", "Bortezomib", "DOID:10811", "nasal cavity cancer", null, 0.001461, 0.132353, 0.612484, 0], ["DB00188", "Bortezomib", "DOID:585", "nephrolithiasis", null, 0.001998, 0.477941, 0.73342, 0], ["DB00188", "Bortezomib", "DOID:0050742", "nicotine dependence", null, 0.001804, 0.426471, 0.63394, 0], ["DB00188", "Bortezomib", "DOID:9970", "obesity", null, 0.006209, 0.963235, 0.842003, 0], ["DB00188", "Bortezomib", "DOID:2174", "ocular cancer", null, 0.002828, 0.661765, 0.972042, 0], ["DB00188", "Bortezomib", "DOID:8398", "osteoarthritis", null, 0.001374, 0.051471, 0.591678, 0], ["DB00188", "Bortezomib", "DOID:11476", "osteoporosis", null, 0.003188, 0.75, 0.836151, 0], ["DB00188", "Bortezomib", "DOID:12185", "otosclerosis", null, 0.001509, 0.183824, 0.644343, 0], ["DB00188", "Bortezomib", "DOID:2394", "ovarian cancer", null, 0.003241, 0.764706, 0.917425, 0], ["DB00188", "Bortezomib", "DOID:1793", "pancreatic cancer", null, 0.002876, 0.669118, 0.816645, 0], ["DB00188", "Bortezomib", "DOID:4989", "pancreatitis", null, 0.001709, 0.404412, 0.620936, 0], ["DB00188", "Bortezomib", "DOID:594", "panic disorder", null, 0.001349, 0.029412, 0.449285, 0], ["DB00188", "Bortezomib", "DOID:11615", "penile cancer", null, 0.001554, 0.279412, 0.678804, 0], ["DB00188", "Bortezomib", "DOID:824", "periodontitis", null, 0.001486, 0.147059, 0.617685, 0], ["DB00188", "Bortezomib", "DOID:1192", "peripheral nervous system neoplasm", null, 0.00329, 0.772059, 0.882315, 0], ["DB00188", "Bortezomib", "DOID:1725", "peritoneum cancer", null, 0.001604, 0.338235, 0.705462, 0], ["DB00188", "Bortezomib", "DOID:0060119", "pharynx cancer", null, 0.001544, 0.220588, 0.721066, 0], ["DB00188", "Bortezomib", "DOID:11612", "polycystic ovary syndrome", null, 0.002477, 0.595588, 0.882965, 0], ["DB00188", "Bortezomib", "DOID:12236", "primary biliary cirrhosis", null, 0.002375, 0.566176, 0.760078, 0], ["DB00188", "Bortezomib", "DOID:10283", "prostate cancer", null, 0.005658, 0.941176, 0.857607, 0], ["DB00188", "Bortezomib", "DOID:8893", "psoriasis", null, 0.003536, 0.801471, 0.853056, 0], ["DB00188", "Bortezomib", "DOID:9008", "psoriatic arthritis", null, 0.002414, 0.573529, 0.786086, 0], ["DB00188", "Bortezomib", "DOID:1993", "rectum cancer", null, 0.001594, 0.323529, 0.73407, 0], ["DB00188", "Bortezomib", "DOID:9835", "refractive error", null, 0.001331, 0.014706, 0.611834, 0], ["DB00188", "Bortezomib", "DOID:0050425", "restless legs syndrome", null, 0.001478, 0.139706, 0.656697, 0], ["DB00188", "Bortezomib", "DOID:5875", "retroperitoneal cancer", null, 0.001534, 0.213235, 0.66775, 0], ["DB00188", "Bortezomib", "DOID:7148", "rheumatoid arthritis", null, 0.002572, 0.625, 0.745774, 0], ["DB00188", "Bortezomib", "DOID:8850", "salivary gland cancer", null, 0.001503, 0.176471, 0.763979, 0], ["DB00188", "Bortezomib", "DOID:1115", "sarcoma", null, 0.002659, 0.639706, 0.882315, 0], ["DB00188", "Bortezomib", "DOID:5419", "schizophrenia", null, 0.002247, 0.529412, 0.775033, 0], ["DB00188", "Bortezomib", "DOID:14268", "sclerosing cholangitis", null, 0.001418, 0.095588, 0.616385, 0], ["DB00188", "Bortezomib", "DOID:4159", "skin cancer", null, 0.003199, 0.757353, 0.893368, 0], ["DB00188", "Bortezomib", "DOID:5612", "spinal cancer", null, 0.001413, 0.080882, 0.587126, 0], ["DB00188", "Bortezomib", "DOID:10534", "stomach cancer", null, 0.00201, 0.485294, 0.677503, 0], ["DB00188", "Bortezomib", "DOID:9074", "systemic lupus erythematosus", null, 0.003172, 0.742647, 0.797139, 0], ["DB00188", "Bortezomib", "DOID:418", "systemic scleroderma", null, 0.004969, 0.919118, 0.93303, 0], ["DB00188", "Bortezomib", "DOID:2998", "testicular cancer", null, 0.003631, 0.830882, 0.940182, 0], ["DB00188", "Bortezomib", "DOID:14004", "thoracic aortic aneurysm", null, 0.00144, 0.117647, 0.680104, 0], ["DB00188", "Bortezomib", "DOID:3277", "thymus cancer", null, 0.001811, 0.433824, 0.737321, 0], ["DB00188", "Bortezomib", "DOID:1781", "thyroid cancer", null, 0.002364, 0.558824, 0.841352, 0], ["DB00188", "Bortezomib", "DOID:11920", "tracheal cancer", null, 0.001603, 0.330882, 0.711313, 0], ["DB00188", "Bortezomib", "DOID:9744", "type 1 diabetes mellitus", null, 0.003169, 0.735294, 0.942133, 0], ["DB00188", "Bortezomib", "DOID:9352", "type 2 diabetes mellitus", null, 0.042166, 1.0, 0.972692, 0], ["DB00188", "Bortezomib", "DOID:8577", "ulcerative colitis", null, 0.004726, 0.904412, 0.86736, 0], ["DB00188", "Bortezomib", "DOID:11819", "ureter cancer", null, 0.001619, 0.367647, 0.716515, 0], ["DB00188", "Bortezomib", "DOID:11054", "urinary bladder cancer", null, 0.003843, 0.845588, 0.914824, 0], ["DB00188", "Bortezomib", "DOID:363", "uterine cancer", null, 0.003816, 0.838235, 0.910273, 0], ["DB00188", "Bortezomib", "DOID:13223", "uterine fibroid", null, 0.001773, 0.419118, 0.758778, 0], ["DB00188", "Bortezomib", "DOID:119", "vaginal cancer", null, 0.001728, 0.411765, 0.769181, 0], ["DB00188", "Bortezomib", "DOID:175", "vascular cancer", null, 0.00149, 0.161765, 0.664499, 0], ["DB00188", "Bortezomib", "DOID:12306", "vitiligo", null, 0.002214, 0.514706, 0.905722, 0], ["DB00188", "Bortezomib", "DOID:1245", "vulva cancer", null, 0.001567, 0.294118, 0.710013, 0]]}